London, June 6, 2026, 22:04 (BST)
- Reckitt gained 1.88% Friday to close at £45.49, though shares remain down about 0.9% from last Friday’s finish.
- Reckitt’s latest filing said the company repurchased 211,000 shares on June 4, paying a volume-weighted average of 4,490.68 pence each.
Reckitt Benckiser Group shares finished higher on Friday, up 1.88% at £45.49, while the FTSE 100 rose 0.07%. Despite the late-week gain, Reckitt Benckiser still closed down about 0.9% from last week’s £45.91 finish, leaving the week in the red.
That’s in play because London is closed for the weekend, leaving investors with two days to think about a small rebound versus bigger troubles. Reckitt remains down over 30% from its January 52-week high, with the market still reacting to weak first-quarter sales and risk to margins from costs.
Investors are looking for hard signs this week, not just talk. The focus is on whether buybacks, new board purchases, and the June rollout of U.S. cold-and-flu lines can move attention off worries over Europe, challenges in the Middle East, and lagging demand for the season.
Reckitt said in a June 5 filing it bought 211,000 ordinary shares from Deutsche Bank AG, London Branch on June 4. The company said it will keep the shares in treasury, holding them instead of leaving them for public trading. The buyback lets Reckitt repurchase its own stock.
The filing listed 4,517 pence as the top price paid, 4,449 pence as the lowest, and a volume-weighted average of 4,490.68 pence. Reckitt said it now has 37.7 million shares in treasury, with 636.3 million ordinary shares in issue, not counting treasury stock.
Chair Jeremy Darroch picked up 2,132 shares at £46.87 each on May 29, according to a regulatory filing from June 2. Non-executive director Tamara Ingram also bought 364 shares at the same price. Both deals came earlier this week. The City tends to watch board buying, especially when the stock faces pressure, but it isn’t a forecast.
Trading is still the main story. Back in April, Reckitt said Core Reckitt like-for-like net revenue rose 1.3% in Q1, stripping out things like currency swings and changes to its portfolio. Excluding seasonal OTC products, it was up 3.1%. Emerging Markets gained 7.6%. Europe dropped 4.2%. North America was off 0.9%.
Reckitt CEO Kris Licht said the quarter took a hit from “very low seasonal incidence, weak categories in Europe and geopolitical disruption,” but left the 2026 like-for-like revenue forecast unchanged. Core Reckitt like-for-like revenue is still set to grow 4% to 5% this year. Reckitt
Reckitt shares dropped as much as 7% after the first-quarter update, according to Reuters. Harsharan Mann at Aviva Investors called the numbers “broad-based muted growth.” JPMorgan’s Celine Pannuti flagged the second-quarter outlook for emerging markets as disappointing, raising questions about full-year targets, Reuters said. Reuters
Unilever ended up 2.71% at £41.89 on Friday and Haleon added 2.18% to £3.37, both outpacing the FTSE 100, which edged higher. The move higher for these consumer stocks wasn’t unique to Reckitt.
Looking to next week, Reckitt says its plan stays on track. The company expects to start shipping Mucinex 12-hour Cold and Fever in North America in June, with Europe set for some recovery as the cold-and-flu season resets. Emerging Markets growth in Q2 should be similar to the first quarter, Reckitt said.
The downside is clear enough. Reckitt said if oil holds at $110 a barrel through 2026, the hit to gross input costs would be about £130 million to £150 million. The company flagged higher commodity prices as a risk for household budgets. Reckitt also listed Russia sanctions, disruption in the Middle East, soft Europe categories, and weaker cold-and-flu trends as headwinds. When the firm talks about margin in basis points, it means hundredths of a percentage point, so a 200-basis-point drop is two percentage points.
Monday’s open may show if Friday’s bounce was just bargain hunting or the first step of a real recovery. The buyback program puts a mechanical floor under the shares. Operating results haven’t followed yet.
